For instance, in patients with PAD, mRNAs of P‐selectin glycoprotein ligand (SELPG), ICAM1, ITGA6, (F11R), and NF‐κB are all up‐regulated targets of PAD‐specific miRNAs. Here, ICAM1 is linked to peripheral arterial disease.